Overview
Jacob Fisher is a primary care provider, practicing in Family Medicine in Guthrie, Oklahoma. Dr. Fisher has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Aplastic Anemia, Type 2 Diabetes (T2D), Acute Cystitis, and Sciatica. Dr. Fisher is currently accepting new patients.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
205 S Academy Rd, Mercy Clinic, Guthrie, OK 73044
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
St Marys Physician Associates LLC
Casey Cochran is a primary care provider, practicing in Family Medicine in Enid, Oklahoma. Dr. Cochran is rated as an Advanced provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Maturity Onset Diabetes of the Young.
Keith Layne is a primary care provider, practicing in Family Medicine in Moore, Oklahoma. Dr. Layne is rated as an Advanced provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Multiple Carboxylase Deficiency, Vitamin B12 Deficiency Anemia, Folate Deficiency, and Subacute Combined Degeneration. Dr. Layne is currently accepting new patients.
Saints Medical Group, LLC
David Dye is a primary care provider, practicing in Family Medicine in Oklahoma City, Oklahoma. Dr. Dye is rated as a Distinguished provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertensive Heart Disease. Dr. Dye is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute CystitisDr. Fisher isExperienced. Learn about Acute Cystitis.
- Aplastic AnemiaDr. Fisher isExperienced. Learn about Aplastic Anemia.
- Bronchiolitis ObliteransDr. Fisher isExperienced. Learn about Bronchiolitis Obliterans.
- Chronic Obstructive Pulmonary Disease (COPD)
- CirrhosisDr. Fisher isExperienced. Learn about Cirrhosis.
- Familial Combined HyperlipidemiaDr. Fisher isExperienced. Learn about Familial Combined Hyperlipidemia.